Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease

Purpose:  Subtotal thyroidectomy has been advocated as the standard treatment for Graves’ disease because of the possibility of avoiding thyroxine therapy as well as the assumed lower risk of complications compared to total thyroidectomy. However, the long‐term results of subtotal thyroidectomy are not as good as they were previously believed to be, as evidenced by the increasing incidence of hypothyroidism. If the risk of complications from total thyroidectomy is no higher, then that procedure offers significant advantages in the surgical management of Graves’ disease. The aim of this study therefore was to compare the complication rate of the two procedures in patients with Graves’ disease.

[1]  S. Mishra,et al.  Total Thyroidectomy for Benign Thyroid Disorders in an Endemic Region , 2000, World Journal of Surgery.

[2]  I. Gough,et al.  Total Thyroidectomy for Management of Thyroid Disease , 2000, World Journal of Surgery.

[3]  L. Delbridge,et al.  Surgeon's Approach to the Thyroid Gland: Surgical Anatomy and the Importance of Technique , 2000, World Journal of Surgery.

[4]  C. Miller,et al.  The efficacy of thyroidectomy for Graves' disease: A meta-analysis. , 2000, The Journal of surgical research.

[5]  L. Delbridge,et al.  Progressive Increase in Thyroid Dysfunction after Subtotal Thyroidectomy for Graves' Disease , 2000 .

[6]  Láudio,et al.  RELATION BETWEEN THERAPY FOR HYPERTHYROIDISM AND THE COURSE OF GRAVES’ OPHTHALMOPATHY , 2000 .

[7]  L. Delbridge,et al.  Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. , 1999, Archives of surgery.

[8]  J. Zedenius,et al.  Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. , 1999, The Australian and New Zealand journal of surgery.

[9]  O. Ozaki,et al.  Effect of Subtotal Thyroidectomy on Natural History of Ophthalmopathy in Graves’ Disease , 1998, World Journal of Surgery.

[10]  M. Nardi,et al.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. , 1998, The New England journal of medicine.

[11]  J. Loré,et al.  Total thyroidectomy for Graves' disease , 1997, Head & neck.

[12]  A. Pinchera,et al.  Surgical treatment of Graves' disease: subtotal or total thyroidectomy? , 1996, Surgery.

[13]  J. Rastad,et al.  Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. , 1995, European journal of endocrinology.

[14]  A. Kung,et al.  The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole. , 1994, The Journal of clinical endocrinology and metabolism.

[15]  F. Jiménez,et al.  Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy , 1993 .

[16]  J. Chigot,et al.  The surgical treatment of Graves' disease. , 1993, Surgery, gynecology & obstetrics.

[17]  E. Torres Vela,et al.  Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. , 1993, The British journal of surgery.

[18]  A. Taube,et al.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. , 1992, The New England journal of medicine.

[19]  M. Fujimori,et al.  Clinical evaluation of the response to surgical treatment of Graves' disease. , 1990, Surgery, gynecology & obstetrics.

[20]  C. Marcocci,et al.  Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. , 1989, The New England journal of medicine.

[21]  P. Laurberg,et al.  RADIOIODINE AND AGGRAVATION OF GRAVES' OPHTHALMOPATHY , 1989, The Lancet.

[22]  M. Davenport,et al.  Thyroidectomy for Graves' disease: is hypothyroidism inevitable? , 1989, Annals of the Royal College of Surgeons of England.

[23]  D. Goga,et al.  Surgical treatment of Graves' disease0 , 1988 .

[24]  N. Matheson,et al.  Outcome of surgery for Graves' disease re‐examined , 1987, The British journal of surgery.

[25]  D. Aron-Rosa,et al.  Malignant exophthalmos after iodine-131 treatment. , 1975, Modern problems in ophthalmology.

[26]  Wang Hk,et al.  Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis. , 1968 .

[27]  B. Hetzel,et al.  Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis. , 1968, Australasian Annals of Medicine.

[28]  L. Eisenberg.  Thyrotoxicosis complicating pregnancy. , 1950, New York state journal of medicine.